Related references
Note: Only part of the references are listed.Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside
Jinghua Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)
William T. McElroy
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Phase 1 Study of CA-4948, a Novel Inhibitor of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in Patients with R/R Non-Hodgkin Lymphoma (NHL)
Anas Younes et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2019)
Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis
Chen Yu et al.
CLINICAL RHEUMATOLOGY (2019)
Critical role of IL-1 in IL-1-induced inflammatory responses: cooperation with NF-Bp65 in transcriptional regulation
Anil K. Singh et al.
FASEB JOURNAL (2019)
Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis
J. Sode et al.
PHARMACOGENOMICS JOURNAL (2018)
Altered Expression of MicroRNAs in Rheumatoid Arthritis
Fataneh Tavasolian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling
Saurav De et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment -Based Drug Design
Katherine L. Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
Arduino A. Mangoni et al.
MEDIATORS OF INFLAMMATION (2017)
Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts
Erika Della Mina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Selected cytokine pathways in rheumatoid arthritis
Melissa Noack et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
IRaK4 Deficiency in a patient with Recurrent pneumococcal Infections: Case Report and Review of the Literature
Karina Gobin et al.
FRONTIERS IN PEDIATRICS (2017)
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors
Rajeev S. Bhide et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2017)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective
Peter C. Taylor et al.
RHEUMATOLOGY INTERNATIONAL (2016)
A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis
Nan Mu et al.
SCIENTIFIC REPORTS (2016)
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
Patricia Lacerte et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and MetaAnalysis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
Divya Chaudhary et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes
Nathan D. Chamberlain et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Experimental and natural infections in MyD88-and IRAK-4-deficient mice and humans
Horst von Bernuth et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis
Fui G. Goh et al.
RHEUMATOLOGY (2012)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus
Maciej Lech et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard et al.
MEDICINE (2010)
IRAK-M regulation and function in host defense and immune homeostasis
Leah L. N. Hubbard et al.
INFECTIOUS DISEASE REPORTS (2010)
IRAK-4 Inhibitors for Inflammation
Zhulun Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
IRAK4 in TLR/IL-1R signaling: Possible clinical applications
Xiaoxia Li
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2
Tatsukata Kawagoe et al.
NATURE IMMUNOLOGY (2008)
Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients
Kaleb M. Pauley et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Selective predisposition to bacterial infections in IRAK-4-deficient children:: IRAK-4-dependent TLRs are otherwise redundant in protective immunity
Cheng-Lung Ku et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis
QiQuan Huang et al.
ARTHRITIS AND RHEUMATISM (2007)
Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor- mediated immune responses but not in TCR signaling
Tatsukata Kawagoe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Crystal structures of IRAK-4 kinase in complex with inhibitors: A serine/threonine kinase with tyrosine as a gatekeeper
Zhulun Wang et al.
STRUCTURE (2006)
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review
Yannis Alamanos et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)
Human TLR-7-,-8-, and -9-mediated induction of IFN-α/β and -λ is IRAK-4 dependent and redundant for protective immunity to viruses
K Yang et al.
IMMUNITY (2005)
Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling
C Kollewe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling
E Lye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pyogenic bacterial infections in humans with IRAK-4 deficiency
C Picard et al.
SCIENCE (2003)
IRAK-4 as the central TIR signaling mediator in innate immunity
N Suzuki et al.
TRENDS IN IMMUNOLOGY (2002)
IRAK-M is a negative regulator of toll-like receptor signaling
K Kobayashi et al.
CELL (2002)
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
N Suzuki et al.
NATURE (2002)
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
P Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Share Paper
